SS Innovations International (SSII) Cash from Financing Activities (2016 - 2026)
SS Innovations International's (SSII) quarterly Cash from Financing Activities came in at $18.2 million in Q1 2026, down 18.95% year-on-year from $22.4 million in Q1 2025, and up 1222.47% quarter-over-quarter from $1.4 million in Q4 2025.
SS Innovations International (SSII) Cash from Financing Activities (2016 - 2026) Analysis & Trends
SS Innovations International has disclosed Cash from Financing Activities across 11 years of filings, most recently posting $18.2 million for Q1 2026.
- Cash from Financing Activities for Q1 2026 came in at $18.2 million, down 18.95% year-over-year; the trailing twelve-month figure through Mar 2026 was $21.9 million (down 24.91% YoY), and the FY2025 annual result was $26.2 million, up 177.6% from the prior year.
- Cash from Financing Activities came in at $18.2 million for Q1 2026 at SS Innovations International, up from $1.4 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $22.4 million in Q1 2025 to a low of -$702098.0 in Q2 2025.
- The 5-year median for Cash from Financing Activities is $2.7 million (2024), against an average of $5.4 million.
- Across the five-year window, Cash from Financing Activities surged 15516.71% in 2022 and sank 126.45% in 2025, its largest moves.
- SS Innovations International's Cash from Financing Activities stood at $3.1 million in 2022, then slumped by 95.1% to $150563.0 in 2023, then jumped by 2165.52% to $3.4 million in 2024, then slumped by 59.74% to $1.4 million in 2025, then jumped by 1222.47% to $18.2 million in 2026.
- The last three Cash from Financing Activities figures came in at $18.2 million (Q1 2026), $1.4 million (Q4 2025), and $3.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -97.90 Mn |
| 10 | SS Innovations International | 689.95 Mn | 666.34 Mn | 5.33 Mn | 18.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.16 Mn |
| Mar 31, 2026 | 18.16 Mn |
| Dec 31, 2025 | 1.37 Mn |
| Dec 31, 2025 | 1.37 Mn |
| Sep 30, 2025 | 3.09 Mn |
| Sep 30, 2025 | 3.09 Mn |
| Jun 30, 2025 | -702,098.00 |
| Jun 30, 2025 | -702,098.00 |
| Mar 31, 2025 | 22.41 Mn |
| Mar 31, 2025 | 22.41 Mn |
| Dec 31, 2024 | 3.41 Mn |
| Dec 31, 2024 | 3.41 Mn |
| Sep 30, 2024 | 722,336.00 |
| Sep 30, 2024 | 722,336.00 |
| Jun 30, 2024 | 2.65 Mn |
| Jun 30, 2024 | 2.65 Mn |
| Mar 31, 2024 | 2.64 Mn |
| Mar 31, 2024 | 2.64 Mn |
| Dec 31, 2023 | 150,563.00 |
| Dec 31, 2023 | 150,563.00 |